HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

doi:10.1086/511035

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Feb 2007

Wilkin Timothy J, Su Zhaohui, Kuritzkes Daniel R, Hughes Michael, Flexner Charles, Gross Robert, Coakley Eoin, Greaves Wayne, Godfrey Catherine, Skolnik Paul R, Timpone Joseph, Rodriguez Benigno, Gulick Roy M

Abstract excerpt

BACKGROUND: Chemokine coreceptor use impacts both the natural history of human immunodeficiency virus type 1 (HIV-1) disease and the potential use of a new class of antiretroviral agents, the CCR5 inhibitors. METHODS: We analyzed HIV-infected patients who were screened for participation in Acquired Immunodeficiency Syndrome (AIDS) Clinical Trial Group protocol A5211, a phase 2b study of the investigational CCR5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Retroviral Agents

Share to CCR5 Receptor Antagonists

Share to CD4 Antigens

Share to Clinical Trials as Topic

Share to Patient Selection

Share to Receptors, CCR5

Share to Receptors, CXCR4

Source

Open in PubMed

Identifiers

PMID: 17243065
DOI: 10.1086/511035

Genes

CCR5
CXCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.PMID 17243065Read ↗

Epidemiology and Predictive Factors for Chemokine Receptor Use in HIV‐1 InfectionSemantic proximity Read ↗

Correlation of coreceptor usage and disease progressionSemantic proximity Read ↗

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.Semantic proximity Read ↗

Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptorsSemantic proximity Read ↗

The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype CSemantic proximity Read ↗

HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism.Semantic proximity Read ↗

Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapySemantic proximity Read ↗

Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission.Semantic proximity Read ↗

HIV‐1 Chemokine Coreceptor Utilization in Paired Cerebrospinal Fluid and Plasma Samples: A Survey of Subjects with ViremiaSemantic proximity Read ↗

Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.Semantic proximity Read ↗

Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.Semantic proximity Read ↗

Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.